Karsten Lindhardt
Chief Scientific Officer,
Egalet Corporation Wayne,
USA
Biography
Dr. Lindhardt has been the initiator of the CCALC Cat 1 focus group, which purpose has been to make meetings for professionals in the abuse deterrence space with a particular interest in the field of in vitro abuse deterrence studies. Dr. Lindhardt is the CSO of Egalet Corp. and has 20 years of experience as scientific manager in the pharmaceutical industry. Dr. Lindhardt has earned a Diploma of Business Excellence (DBE) at Columbia University, Copenhagen Business School. Dr. Lindhardt received a M.Sci. in Pharmaceutics and a Ph.D. in pharmaceutical development and pharmacology, each from the Royal Danish School of Pharmacy, Copenhagen DK.
Research Interest
In vitro abuse deterrence studies, Pharmaceutical Industry